Accelerated onset and increased severity of acute graft-versus-host disease following adoptive transfer of DR6-deficient T cells

Journal of Immunology

Volumn 169, Issue 7, 2002, Pages 3993-3998

  Liu, Jinqi ^a   Heuer, Josef G ^a   Na, Songqing ^a   Galbreath, Elizabeth ^a   Zhang, Tonghai ^a   Yang, Derek D ^a   Glasebrook, Andrew ^a   Song, Ho Yeong ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CD4 ANTIGEN; CD8 ANTIGEN; LIGAND; TUMOR NECROSIS FACTOR RECEPTOR;

ALLOGENEIC RESTRICTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW TRANSPLANTATION; CELL ACTIVATION; CELL PROLIFERATION; CELL TRANSFER; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; GRAFT VERSUS HOST REACTION; HISTOPATHOLOGY; IMMUNE RESPONSE; INTESTINE; MALE; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN; T LYMPHOCYTE; TH2 CELL; THYMUS; WEIGHT REDUCTION;

EID: 0036784654     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.169.7.3993     Document Type: Article

References (34)

1. Martin, P. J., J. A. Hansen, R. Storb, and E. D. Thomas. 1987. Human marrow transplantation: an immunological perspective. Adv. Immunol. 40:379.
2. Chao, N. J. 1994. Graft-versus-Host Disease: Past, Present and Future. R. G. Landes, Austin, TX, pp. 639-666.
3. Anasetti C., and J. Hansen. 1993. Bone marrow transplantation from HLA-partially matched related donors and unrelated volunteer donors. In Bone Marrow Transplantation. S. J. Forman, K. G. Blume, and E. D. Thomas, eds. Blackwell Scientific, Cambridge, MA, p. 665.
4. Korngold, R., and J. Sprent. 1978. Lethal graft-versus-host disease after bone marrow transplantation across minor histocompatibility barriers in mice, J. Exp. Med. 148:1687.
5. Prentice H. G., G. Janossy, D. Skeggs, H. A. Blacklock, K. F. Bradstock, G, Goldstein, and A. V. Hoffbrand. 1982. Use of anti-T-cell monoclonal antibody OKT3 to prevent acute graft-versus-host disease in allogeneic bone marrow transplantation for acute leukemia. Lancet 2:700.
6. Martin, P. J., and N. A. Kernan. 1996. T cell depletion for the prevention of graft-versus-host disease in man. In Graft Versus Host Disease: Research and Clinical Management. S. Burakoff, M. J. Deeg, J. Ferrara, and K. Atkinson, eds. Dekker, New York, p. 615.
7. Giralt, S. A., and R. E. Champlin. 1994. Leukemia relapse after allogeneic bone marrow transplantation. Blood 84:3603.
8. Apperley, J. F., L. Jones, G. Hale, and J. M. Goldman. 1986. Bone marrow transplantation for chronic myeloid leukemia: T cell depletion with Campath-I reduces the incidence of acute graft-versus-host disease but may increase the risk of leukemia relapse. Bone Marrow Transplant. 1:53.
9. Antin, J. H., and J. L. Ferrara. 1992. Cytokine dysregulation and acute graftversus-host disease. Blood 80:2964.
10. Hill, G. R., W. Krenger, and J. L. M. Ferrara. 1997. The role of cytokines in acute graft-versus-host disease. Cytokines Cell. Mol. Ther. 3:257.
11. Hill, G. R., J. M. Crawford, K. R. Cooke, Y. S. Brinson, L. Pan, and J. L. M. Ferrara. 1997. Total body irradiation effects on acute graft versus host disease: the role of gastrointestinal damage and inflammatory cytokines. Blood 90:3204.
12. Nestel, F. P., K. S. Price, T. A. Seemayer, and W. S. Lapp. 1992. Macrophage priming and lipopolysaccharide-triggered release of tumor necrosis factor a during graft-versus-host disease. J. Exp. Med. 175:405.
13. Braun, Y. M., B. Lowin, L. French, H. Acha-Orbea, and J. Tschopp. 1996. Cytotoxic T cells deficient in both functional Fas ligand and perforin show residual cytolytic activity yet lose their capacity to induce lethal acute graft-versus-host disease. J. Exp. Med. 183:657.
14. Baker, M. B., N. H. Altman, E. R. Podack, and R. B. Levy. 1996. The role of cell-mediated cytotoxicity in acute GVHD after MHC-matched allogeneic bone marrow transplantation in mice. J. Exp. Med. 183:2645.
15. Piguet, P. F., G. E. Grau, B. Allet. and P. Vassalli. 1987. Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs-host disease. J. Exp. Med. 166:1280.
16. Mowat, A. M. 1989. Antibodies to IFN-γ prevent immunologically mediated intestinal damage in murine graft-versus-host reaction. Immunology 68:18.
17. Pan, G., J. H. Bauer, V. Haridas, S. Wang, D. Liu, G. Yu, C. Vincenz, B. B. Aggarwal, J. Ni, and V. M. Dixit. 1998. Identification and functional characterization of DR6, a novel death domain-containing TNF receptor. FEBS Lett. 431:351.
18. Wallach, D., E. E. Varfolomeev, N. L. Malinin, Y. V. Goltsev, A. V. Kovalenko, and M. P. Boldin. 1999. Tumor necrosis factor receptor and Fas signaling mechanisms. Annu. Rev. Immunol. 17:331.
19. + T cell proliferation and Th2 cytokine production in DR6-deficient mice. Immunity 15:23.
20. 1 mice injected with parental lymphocytes. J. Immunol. 146:2108.
21. Via, C. S., and G. M. Shearer. 1988. T-cell interactions in autoimmunity: insights from a murine model of graft-versus-host disease. Immunol. Today 9:207.
22. Okunewich, J. P., R. F. Meredith, B. J. Brozovich, P. R. Seeman, and K. Magliere. 1980. Exponential relationship between spleen cell concentration and fatal graft-versus-host response after transplantation of allogeneic spleenmarrow cell mixtures. Transplantation 29:507.
23. Yu, X.-Z., P. J. Martin, and C. Anasetti. 1998. The role of CD28 in acute graft-versus-host disease. Blood 92:2963.
24. Yu, X.-Z., S. J. Bidwell, P. J. Martin. and C. Anasetti. 2000. CD28-specific antibody prevents graft-versus-host disease in mice. J. Immunol. 164:4564.
25. + T cells. J. Immunol. 157: 3250.
26. Blazar, B. R., P. A. Taylor, A. Panoskaltsis-Martari, A. H. Sharpe, and D. A. Vallera. 1999. Opposing roles of CD28:B7 and CTLA-4:B7 pathways in regulating in vivo alloresponses in murine recipients of MHC disparate T cells. J. Immunol. 162:6368.
27. Cooke, K. R., G. R. Hill, J. M. Crawford, D. Bungard, Y. S. Brinson, J. Delmonte, and J. L. M. Ferrara. 1998. Tumor necrosis factor-α production to lipopolysaccharide stimulation by donor cells predicts the severity of experimental acute graft-versus-host disease. J. Clin. Invest. 102:1882.
28. Hill, G. R., T. Teshima, A. Gerbitz, L. Pan, K. R. Cooke, Y. S. Brinson, J. M. Crawford, and J. L. M. Ferrara. 1999. Differential roles of IL-1 and TNF-α on graft-versus-host disease and graft versus leukemia. J. Clin. Invest. 104:459.
29. Hattori, K., T. Hirano, H. Miyajima, N. Yamakawa, M. Tateno, K. Oshimi, N. Kayagaki, H. Yagita, and K. Okumura. 1998. Differential effects of anti-Fas ligand and anti-tumor necrosis factor a antibodies on acute graft-versus-host disease pathologies. Blood 91:4051.
30. Wall, D. A., and K. C. Sheehan. 1994. The role of tumor necrosis factor α and IFN-γ in graft-versus-host disease and related immunodeficiency. Transplantation 57:273.
31. Hattori, K., T. Hirano. C. Ushiyama, H. Miyajima, N. Yamakawa, T. Ebata, Y. Wada, S. Ikeda, K. Yoshino, M. Tateno, et al. 1997. A metalloproteinase inhibitor prevents lethal acute graft-versus-host disease in mice. Blood 90:542.
32. low thymocytes. Blood 94:1890.
33. Dulude, G., D.-C. Roy, and C. Perreault. 1999. The effect of graft-versus-host disease on T cell production and homeostasis. J. Exp. Med. 189:1329.
34. Andjelic, S., J. Drappa, E. Lacy, K. B. Elkon, and J. Nikolic-Zugic. 1994. The onset of Fas expression parallels the acquisition of CD8 and CD4 in fetal and adult αβ thymocytes. Int. Immunol. 6:73.